Learn more about the future direction of the Life Sciences industry in the U.S. by accessing key sessions from the 2012 LES (USA & Canada) Spring Meeting.
Learn more about the future direction of the Life Sciences industry in the U.S. by accessing these key sessions from the 2012 LES (USA & Canada) Spring Meeting:
Licensing as a Source of Innovation
Genzyme CEO David Meeker
Plenary Panel: Licensing to Solve the Innovation Gap
Featuring:
Daniel Behr, Access BridgeGap Ventures
Jeff Elton, Accenture
Robert Langer, MIT
These sessions are available to all LES members worldwide for the preferred rate of $159.00 for both sessions, or $100.00 for each session.
To purchase your session and download the content, visit:
